Truebeam

RaySearch Enters Into Interoperability Agreement With Varian

Retrieved on: 
Thursday, May 28, 2020
Radiation therapy, Varian Medical Systems, Truebeam, Business, Articles, Medical technology, RaySearch Laboratories, Interoperability, Workflow, Varian

STOCKHOLM, May 28, 2020 /PRNewswire/ -- RaySearch Laboratories AB (publ) and Varian Medical Systems have entered into an interoperability agreement that will allow the RayCare* oncology information system to connect to Varian TrueBeam linear accelerators.

Key Points: 
  • STOCKHOLM, May 28, 2020 /PRNewswire/ -- RaySearch Laboratories AB (publ) and Varian Medical Systems have entered into an interoperability agreement that will allow the RayCare* oncology information system to connect to Varian TrueBeam linear accelerators.
  • Under the announced agreement, a dedicated interface has been defined which allows RayCare and Varian TrueBeam to communicate the data necessary for an integrated workflow.
  • This means that clinics will be able to use RayCare to manage all clinical activities around their Varian TrueBeam accelerators.
  • Interoperability with Varian TrueBeam will significantly expand the market potential for RayCare and improve the workflow for our existing customers."

VCA Announces Partnership with Varian in the Fight Against Pet Cancer

Retrieved on: 
Tuesday, November 12, 2019
VCA Animal Hospitals, Truebeam, VCA, Varian, Veterinary physician, Halcyon, Medicine, Health

SANTA MONICA, Calif., Nov. 12, 2019 /PRNewswire/ --VCA Animal Hospitals announced today a partnership with Varian, as part of its newly launched network of VCA Pet CancerCare Centers across North America, to provide advanced pet cancer radiotherapy treatment at its specialty hospitals.

Key Points: 
  • SANTA MONICA, Calif., Nov. 12, 2019 /PRNewswire/ --VCA Animal Hospitals announced today a partnership with Varian, as part of its newly launched network of VCA Pet CancerCare Centers across North America, to provide advanced pet cancer radiotherapy treatment at its specialty hospitals.
  • Many VCA Pet CancerCare Centers will install a fully integrated suite of Varian products, including its ARIA and Eclipse software platforms and TrueBeam or Halcyon radiotherapy systems.
  • "We're thrilled to embark on this journey with VCA and their Pet CancerCare Centers," said Eric Stewart, Global Managing Director, Veterinary Oncology at Varian.
  • The first five Pet CancerCare Centers to receive Varian radiotherapy systems include, VCA California Veterinary Specialists , in Carlsbad, CA; VCA Sacramento Vet Referral in California, VCA Advanced Veterinary Care Center in Fishers, Indiana; VCA Aurora Animal Hospital in Illinois ; and VCA SouthPaws Veterinary Specialists & Emergency Center in Fairfax, Virginia.

RSSearch® Patient Registry Surpasses 25,000 Patient Cases Using Stereotactic Body Radiotherapy/Stereotactic Radiosurgery

Retrieved on: 
Friday, September 13, 2019
Medicine, Medical specialties, Clinical medicine, Neurosurgery, Radiobiology, Medical physics, Radiosurgery, Stereotactic surgery, Radiation therapy, SRS, Therapy, Truebeam

SAN MATEO, Calif., Sept. 13, 2019 /PRNewswire-PRWeb/ --The Radiosurgery Society (RSS), a non-profit organization of medical professionals dedicated to advancing the science and clinical practice of stereotactic body radiotherapy (SBRT) and radiosurgery (SRS), announced today that its RSSearch Patient Registry has surpassed 25,000 patient cases treated with SRS/SBRT.

Key Points: 
  • SAN MATEO, Calif., Sept. 13, 2019 /PRNewswire-PRWeb/ --The Radiosurgery Society (RSS), a non-profit organization of medical professionals dedicated to advancing the science and clinical practice of stereotactic body radiotherapy (SBRT) and radiosurgery (SRS), announced today that its RSSearch Patient Registry has surpassed 25,000 patient cases treated with SRS/SBRT.
  • "The RSSearch Registry is a gold mine of data, diligently gathered by dedicated providers across the globe, to provide valuable insight into real-world outcomes of SRS/SBRT treatments.
  • The RSSearch Patient Registry is an observational registry established to standardize data collection from patients treated with SRS/SBRT.
  • Originally formed in 2002 and becoming 501(c)(6) in 2008, the Radiosurgery Society today ( http://www.therss.org ) represents approximately 700 members who perform stereotactic body radiotherapy and radiosurgery in hospitals and freestanding centers throughout the world.

Qfix® kVue™ One Modular Couch Top Validated for Use with Varian® Radiotherapy Systems

Retrieved on: 
Friday, April 12, 2019
Couch, Furniture, Upholstery, Truebeam, KVUE, Interoperability, Backward compatibility, Computing, Technology, Digital technology

The revolutionary kVue One couch top is compatible with and validated on Varian's TrueBeam, Edge and VitalBeam Radiotherapy Systems (software version 2.7 and higher, excluding interoperability with HyperArc).

Key Points: 
  • The revolutionary kVue One couch top is compatible with and validated on Varian's TrueBeam, Edge and VitalBeam Radiotherapy Systems (software version 2.7 and higher, excluding interoperability with HyperArc).
  • The kVue One interfaces with 4 and 6 Degree of Freedom couches and is compatible with the Calypso real-time motion tracking system.
  • kVue One provides higher weight ratings than previous couch tops, up to 500lbs (226kg) when combined with most couch bases.
  • The kVueOne couch topis backwards compatible with all currently available kVue Inserts, reducing the traditional costs associated with upgrading equipment.

Korea University Medical Center Completes First Varian Halcyon System Treatment in Korea

Retrieved on: 
Tuesday, March 26, 2019
Medical physics, Radiation therapy, Medicine, Radiobiology, Branches of biology, Academic disciplines, Halcyon, Varian, Radiation treatment planning, Anam, Korea University, Truebeam

PALO ALTO, Calif. and SEOUL, South Korea, March 26, 2019 /PRNewswire/ --Varian (NYSE: VAR) today announced a 55-year-old male with liver cancer at the Korea University Medical Center Anam Hospital, was the first patient in Korea to receive treatment on the Halcyon system.

Key Points: 
  • PALO ALTO, Calif. and SEOUL, South Korea, March 26, 2019 /PRNewswire/ --Varian (NYSE: VAR) today announced a 55-year-old male with liver cancer at the Korea University Medical Center Anam Hospital, was the first patient in Korea to receive treatment on the Halcyon system.
  • The Varian Halcyon system simplifies and enhances virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT), including improved patient comfort and shortening the time from installation to first-treatmentwithout sacrificing quality.
  • "By utilizing Halcyon along with Varian's ARIA oncology information system and Eclipse treatment planning software, we strongly believe we can take our excellent patient care to the next level," said Suk Lee, Ph.D, chief medical physicist, Korea University Medical Center Anam Hospital.
  • 'We are proud of our partnership with the Korea University Medical Center Anam Hospital to make Halcyon treatments available to cancer patients in Korea," said Kenneth Tan, senior managing director Southeast Asia and Korea, Varian.

Varian Eclipse and TrueBeam Named Category Leaders in the 2019 Best in KLAS: Software and Services Report

Retrieved on: 
Wednesday, February 6, 2019
Radiation therapy, Medicine, Health sciences, Branches of biology, Radiobiology, Medical physics, Neurosurgery, Imaging, Truebeam, Radiosurgery, Radiation treatment planning, Therapy

The Eclipse software incorporates unique features such as HyperArc high definition radiotherapy (HDRT)treatment planning for intracranial radiosurgery, RapidPlan knowledge-based planning, and multi-criteria optimization (MCO).

Key Points: 
  • The Eclipse software incorporates unique features such as HyperArc high definition radiotherapy (HDRT)treatment planning for intracranial radiosurgery, RapidPlan knowledge-based planning, and multi-criteria optimization (MCO).
  • According to the 2019 Best in KLAS report, Eclipse received the highest average score for overall performance.
  • KLAS created the Radiation Therapy category in 2018, and Varian's TrueBeam has now been named Category Leader both years of the ranking.
  • "To view the Radiation Therapy Category Leaders report visit https://klasresearch.com/best-in-klas-ranking/radiation-therapy/2019/151
    "We are honored once again to have both Eclipse and TrueBeam recognized as a Category Leaders by KLAS," said Dow Wilson, president and chief executive officer, Varian.

Radiotherapy Market Worth $6.8 Billion by 2023 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, January 10, 2019
Medicine, Radiation therapy, Health, External beam radiotherapy, Stereotactic surgery, Therapy, Truebeam, Cyberknife

Based on type, the external beam Radiotherapy Market is classified into IGRT, IMRT, stereotactic therapy, particle beam therapy, and 3D-CRT.

Key Points: 
  • Based on type, the external beam Radiotherapy Market is classified into IGRT, IMRT, stereotactic therapy, particle beam therapy, and 3D-CRT.
  • The Radiotherapy Market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World.
  • The North American region is expected to account for the largest share of the Radiotherapy Market in 2018.
  • Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM".

Radiotherapy Market Worth $6.8 Billion by 2023 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, January 10, 2019
Medicine, Radiation therapy, Health, External beam radiotherapy, Stereotactic surgery, Therapy, Truebeam, Cyberknife

Based on type, the external beam Radiotherapy Market is classified into IGRT, IMRT, stereotactic therapy, particle beam therapy, and 3D-CRT.

Key Points: 
  • Based on type, the external beam Radiotherapy Market is classified into IGRT, IMRT, stereotactic therapy, particle beam therapy, and 3D-CRT.
  • The Radiotherapy Market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World.
  • The North American region is expected to account for the largest share of the Radiotherapy Market in 2018.
  • Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM".

Varian to Demonstrate Advanced Cancer Care Solutions at ESTRO 37

Retrieved on: 
Thursday, April 19, 2018
Medicine, Radiation therapy, Medical physics, Radiobiology, Neurosurgery, Radioactivity, Stereotactic surgery, Truebeam, Varian Medical Systems

Additional Varian solutions being demonstrated at ESTRO 37 includes:

Key Points: 
  • Additional Varian solutions being demonstrated at ESTRO 37 includes:
    RapidPlan with multicriteria optimization (MCO) - RapidPlan is designed to simplify and accelerate the planning process for sophisticated cancer treatments like SRS, stereotactic body radiotherapy (SBRT), intensity-modulated radiotherapy (IMRT), and RapidArc radiotherapy.
  • Varian is hosting an international oncology summit for customers to kick off its ESTRO activities on April 20that the Palau Congressos Barcelona.
  • Varian is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer.
  • Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world.For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.